問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Principal Investigator
顏家瑞
下載
2017-01-20 - 2025-08-15
Condition/Disease
Test Drug
Participate Sites7Sites
Terminated7Sites
2024-03-08 - 2030-05-31
Participate Sites5Sites
Not yet recruiting3Sites
Recruiting2Sites
2018-01-01 - 2027-12-31
Participate Sites4Sites
Recruiting4Sites
2020-12-01 - 2024-05-24
Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer, Gastric Cancer, Colorectal Cancer, Glioblastoma Biliary Tract Cancers, Pancreatic Cancer
LenvimaR capsules/KeytrudaR injection
Participate Sites2Sites
2015-12-01 - 2026-12-31
Recruiting5Sites
2014-05-01 - 2016-01-01
Participate Sites6Sites
Terminated6Sites
2021-10-22 - 2023-07-14
2024-04-01 - 2030-01-31
Breast Neoplasms 、Gastroesophageal Junction Adenocarcinoma
Dry powder injection Film-coated tablets
2016-02-24 - 2030-09-30
全部
